Prognostic value of cardiac magnetic resonance imaging for idiopathic pulmonary arterial hypertension before initiating intravenous prostacyclin therapy.
about
Optimal management of pulmonary arterial hypertension: prognostic indicators to determine treatment courseCardiac magnetic resonance findings predicting mortality in patients with pulmonary arterial hypertension: a systematic review and meta-analysisUse of pulmonary arterial hypertension-approved therapy in the treatment of non-group 1 pulmonary hypertension at US referral centersNon-invasive evaluation of pulmonary arterial blood flow and wall shear stress in pulmonary arterial hypertension with 3D phase contrast magnetic resonance imaging.2014 Guidelines of Taiwan Society of Cardiology (TSOC) for the Management of Pulmonary Arterial Hypertension.Noninvasive imaging for the diagnosis and prognosis of pulmonary hypertension.Cardiac MRI as a diagnostic tool in pulmonary hypertension.Imaging of the right heart--CT and CMR.Assessment of right ventricular function in pulmonary hypertension.Imaging right ventricular function to predict outcome in pulmonary arterial hypertension.Non-invasive imaging of global and regional cardiac function in pulmonary hypertension.Bosentan-based, treat-to-target therapy in patients with pulmonary arterial hypertension: results from the COMPASS-3 study.Sex differences in hemodynamic responses and long-term survival to optimal medical therapy in patients with pulmonary arterial hypertension.Severe pulmonary arterial hypertension: stratification of medical therapies, mechanical support, and lung transplantation.
P2860
Q27023074-39B72A8D-B124-4FA9-9AF1-47E44769BCB5Q28073172-150B0B4F-63BF-4D29-AE59-94BAC7C25F88Q35665777-101A62A7-38C9-474B-912C-C3365AB37ACCQ36086944-23097598-75B0-4C2D-8A9C-7EF26CF33D47Q36777766-F8DF2070-891D-4740-BF23-325F1FA76A08Q38169773-7E4825DE-9A30-40C9-A18A-394907B4DE96Q38171829-EF5E36F1-A639-4E34-A71B-CCB078908B90Q38253105-6B9A1E40-747E-4487-9E63-D4ED6550B270Q38400724-083372DB-E96B-47AF-8C4E-71F00F315575Q40730769-51434100-99EF-42AA-8C62-649EC25D6B86Q47259542-3FE6EC93-0F00-4C13-A84F-8E2C4D8DDFAAQ47879895-0736401B-D9D8-4317-BA26-9D705F3F51D1Q50021216-F71261F8-ACAF-42F5-9117-8AC5F4A68A1BQ54116664-31F77960-E3B1-4C6A-9F5B-0E24EAFCC35B
P2860
Prognostic value of cardiac magnetic resonance imaging for idiopathic pulmonary arterial hypertension before initiating intravenous prostacyclin therapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Prognostic value of cardiac ma ...... ravenous prostacyclin therapy.
@en
Prognostic value of cardiac ma ...... ravenous prostacyclin therapy.
@nl
type
label
Prognostic value of cardiac ma ...... ravenous prostacyclin therapy.
@en
Prognostic value of cardiac ma ...... ravenous prostacyclin therapy.
@nl
prefLabel
Prognostic value of cardiac ma ...... ravenous prostacyclin therapy.
@en
Prognostic value of cardiac ma ...... ravenous prostacyclin therapy.
@nl
P2093
P356
P1433
P1476
Prognostic value of cardiac ma ...... ravenous prostacyclin therapy.
@en
P2093
Akihiro Tanimoto
Keiichi Fukuda
Masaharu Kataoka
Sachio Kuribayashi
Shigeo Okuda
Takayuki Abe
Toru Satoh
Yuichi Tamura
P304
P356
10.1253/CIRCJ.CJ-11-1237
P577
2012-04-12T00:00:00Z